|
Suven Life Sciences Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
2965.58 Cr.
|
P/BV
|
15.39
|
Book Value (Rs.)
|
8.84
|
|
52 Week High/Low (Rs.)
|
169/83
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
02/08/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -4.82 | -6.63 | -9.57 | -5.67 | -7.40 |
| Diluted EPS (Rs.) | -4.82 | -6.63 | -9.57 | -5.67 | -7.40 |
| Cash EPS (Rs.) | -4.52 | -5.12 | -8.09 | -5.33 | -7.07 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 12.38 | 17.21 | 6.61 | 8.49 | 11.26 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 12.38 | 17.21 | 6.61 | 8.49 | 11.26 |
| Revenue From Operations / Share (Rs.) | 0.53 | 0.62 | 0.81 | 1.06 | 1.13 |
| PBDIT / Share (Rs.) | -4.90 | -5.39 | -8.05 | -5.68 | -7.99 |
| PBIT / Share (Rs.) | -5.20 | -5.69 | -8.35 | -6.02 | -8.32 |
| PBT / Share (Rs.) | -4.86 | -5.42 | -8.39 | -6.09 | -8.36 |
| Net Profit / Share (Rs.) | -4.82 | -5.42 | -8.39 | -5.67 | -7.40 |
| NP After MI And SOA / Share (Rs.) | -4.82 | -5.42 | -8.39 | -5.67 | -7.40 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | -914.01 | -867.37 | -988.42 | -536.50 | -705.39 |
| PBIT Margin (%) | -969.62 | -915.70 | -1025.51 | -568.75 | -734.31 |
| PBT Margin (%) | -907.20 | -873.52 | -1029.98 | -574.80 | -738.14 |
| Net Profit Margin (%) | -898.63 | -873.52 | -1029.98 | -535.31 | -653.62 |
| NP After MI And SOA Margin (%) | -898.63 | -873.52 | -1029.98 | -535.31 | -653.62 |
| Return on Networth / Equity (%) | -38.91 | -31.51 | -126.88 | -66.80 | -65.72 |
| Return on Capital Employeed (%) | -41.77 | -32.81 | -121.80 | -68.13 | -68.10 |
| Return On Assets (%) | -36.88 | -30.41 | -112.92 | -56.18 | -51.78 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 |
| Asset Turnover Ratio (%) | 0.03 | 0.02 | 0.03 | 0.04 | 0.04 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 18.99 | 22.61 | 8.01 | 6.45 | 2.49 |
| Quick Ratio (X) | 18.94 | 22.61 | 8.01 | 6.45 | 2.49 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | -674.71 | -406.21 | -220.85 | -88.68 | -184.40 |
| Interest Coverage Ratio (Post Tax) (%) | -709.43 | -428.84 | -229.14 | -87.49 | -169.87 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 2010.22 | 872.72 | 1343.38 | 849.81 | 258.38 |
| EV / Net Operating Revenue (X) | 171.92 | 64.46 | 113.42 | 63.05 | 17.92 |
| EV / EBITDA (X) | -18.81 | -7.43 | -11.47 | -11.75 | -2.54 |
| MarketCap / Net Operating Revenue (X) | 185.94 | 78.07 | 113.85 | 66.48 | 18.90 |
| Price / BV (X) | 8.05 | 2.82 | 14.02 | 8.30 | 1.90 |
| Price / Net Operating Revenue (X) | 185.97 | 78.08 | 113.85 | 66.48 | 18.90 |
| EarningsYield | -0.04 | -0.11 | -0.09 | -0.08 | -0.34 |
